Kancera AB (publ) (“Kancera”) today announces that the board has decided to initiate a process to seek potential stakeholders for a reverse take over of the company with the aim to materialize the value of its public listing. Kancera assesses that the company’s listing at the Nasdaq First North Growth Market in Stockholm together with its cash may be of a significant value. The decision was made after a review of the company’s strategic options showing significant difficulties in driving the business forward in the context of the continued challenging conditions in the capital markets.
The strategic review
Kancera’s business model has been based on developing candidate drugs that can be commercialized through partnerships with…